Table 3 Review of the clinical description of SMARCB1 mutation patients affected with non-rhabdoid tumors
From: SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
Reference | Clinical context | Observation |
|---|---|---|
[2] | 1 familial schwannomatosis | case report, initial description |
[3] | 28 sporadic + 15 familial non-vestibular schwannomatosis patients | 2/28 + 5/15 mutations |
[4] | 1 familial schwannomatosis with multiple meningiomas | case report |
[5] | 47 NF2-negative patients with multiple meningiomas | 0/47 |
[9] | 21 sporadic schwannomatosis patients | 1/21 mutation |
[10] | 1 familial meningiomatosis | case report |